Results 191 to 200 of about 80,296 (266)

Chondroid Soft Tissue Tumors With FOS::PABPN1 Fusion: A New Entity? About Two Cases

open access: yesGenes, Chromosomes and Cancer, Volume 65, Issue 8, August 2026.
ABSTRACT Soft tissue tumors with chondroid matrix represent a heterogeneous group with persistent diagnostic challenges. Advances in molecular diagnostics have identified recurrent gene fusions in several chondroid neoplasms, predominantly involving FN1. Here, we report two cases of chondroid tumors harboring a novel FOS::PABPN1 fusion.
Jinane Kharmoum   +7 more
wiley   +1 more source

AI-Guided Discovery of Oncogenic Signaling Crosstalk in Tumor Progression and Drug Resistance. [PDF]

open access: yesOncol Res
Sutanto E   +6 more
europepmc   +1 more source

Targeted Interventions in HAM/TSP: Emerging Therapies and Future Directions – A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aim Human T‐Lymphotropic virus type 1 (HTLV‐1) infection can lead to HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), a debilitating chronic neurological disease characterized by progressive lower limb spasticity and autonomic dysfunction.
Meygol Mirzaei Rezaei   +11 more
wiley   +1 more source

Beyond Tradition: An Integrated Toxicological, Ecological, and Public Health Perspective on Aristolochic Acids

open access: yesJournal of Applied Toxicology, Volume 46, Issue 8, Page 2599-2622, August 2026.
ABSTRACT Aristolochia species have long been used in traditional medicine for their presumed anti‐inflammatory, analgesic and antimicrobial properties. However, extensive toxicological and epidemiological evidence now demonstrates that these plants contain aristolochic acids (AAs) I and II, highly potent nephrotoxic, genotoxic, and carcinogenic ...
Victor Ventura de Souza   +2 more
wiley   +1 more source

Beyond a Metabolite: Lactylation as a Pivotal Regulator of Colorectal Cancer Pathogenesis and Treatment Resistance

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 8, August 2026.
This review elucidates how lactylation, a novel histone modification driven by lactate, regulates colorectal cancer pathogenesis. We summarize its roles in tumor progression, metastasis, stemness, immunosuppression, and therapy resistance, and discusses the promising therapeutic strategies of targeting the lactylation pathway.
Shuilan Yao   +4 more
wiley   +1 more source

Salivary miR-34a Exhibits State-Dependent Dysregulation Across Normal Oral Mucosa, Premalignant Lesions and Oral Squamous Cell Carcinoma. [PDF]

open access: yesGenes (Basel)
Gintoni I   +7 more
europepmc   +1 more source

USP1 Promotes Malignant Progression of Cervical Cancer Cells by Deubiquitinating and Stabilizing ATG13 to Enhance Autophagic Activity

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 8, August 2026.
USP1, overexpressed in cervical cancer and linked to advanced pathological grade, promotes cervical cancer progression by deubiquitinating and stabilizing ATG13 to enhance autophagy, and USP1 inhibitor ML323 can reverse this oncogenic effect, making USP1 a promising therapeutic target for cervical cancer.
Chunyan Liu   +4 more
wiley   +1 more source

Elucidating the Mechanisms of Trichloroethylene‐Induced Kidney Cancer: Network Toxicology, Molecular Docking, and In Vitro Validation

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 8, August 2026.
An integrated network toxicology, molecular docking, and in vitro validation approach was applied to identify TP53, ACTB, and CASP3 as key targets mediating trichloroethylene‐driven kidney carcinogenesis via aberrant signaling regulation. ABSTRACT Trichloroethylene (TCE), a pervasive environmental contaminant, is epidemiologically linked to kidney, but
Weijie Ma, Hui Cai
wiley   +1 more source

Home - About - Disclaimer - Privacy